Understanding the changes in Alzheimer's disease biomarkers

Statistical Models of Alzheimer's Disease Pathological Cascade

NIH-funded research Johns Hopkins University · NIH-10636802

This study is looking at how certain biological signs related to Alzheimer's disease connect with the symptoms people experience, using data from various sources to help us better understand the disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University NIH-funded
Lab location1 site (Baltimore, United States)
Project IDNIH-10636802 on NIH RePORTER

What this research studies

This research investigates the complex changes in biomarkers associated with Alzheimer's disease (AD) and how these changes relate to clinical symptoms. By developing advanced statistical models, the research aims to validate existing hypothetical models of AD pathology that have not yet been confirmed. The study will analyze data from multiple Alzheimer's databases to provide insights into the relationship between biological markers and clinical manifestations of the disease. This approach seeks to enhance our understanding of the Alzheimer's disease process, which is often difficult to observe directly.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or those at risk of developing it.

Not a fit: Patients with other forms of dementia unrelated to Alzheimer's disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnostic tools and treatment strategies for Alzheimer's disease.

How similar studies have performed: Previous research has shown promise in using statistical models to understand Alzheimer's disease, but this approach aims to validate and refine existing hypotheses.

Where this research is happening

Baltimore, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.